P, M., K, Ś., P, K., Y, B., & A, P. (2023). The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials. Biomedicines, 11(10), . https://doi.org/10.3390/biomedicines11102636
Chicago Style (17th ed.) CitationP, Moćko, Śladowska K, Kawalec P, Babii Y, and Pilc A. "The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials." Biomedicines 11, no. 10 (2023). https://doi.org/10.3390/biomedicines11102636.
MLA (9th ed.) CitationP, Moćko, et al. "The Potential of Scopolamine as an Antidepressant in Major Depressive Disorder: A Systematic Review of Randomized Controlled Trials." Biomedicines, vol. 11, no. 10, 2023, https://doi.org/10.3390/biomedicines11102636.